market expansion

Your key to unlocking the U.S. healthcare market

Web Header Philadelphia skyline

U.S. Market Access

Built for growth-ready global medtech, diagnostics, device, and digital health companies seeking meaningful support, strong stakeholder engagement, and a solid foundation for market expansion.

We open the right doors—to health systems, payers, investors, and regulators—so you don't waste time or money figuring it out alone. For companies ready to move beyond demo days and roadshows, we offer a high-touch experience that accelerates growth, sharpens strategy, and delivers real opportunities.

Eli Velasquez

Capital Advisor

  • Now Accepting Applications

    Virtual sessions begin 23 February 2026
    Onsite intensive: 16-20 March 2026

    apply now

    applications close november 14

High-Touch Support for High-Growth Companies

Confident U.S. Market Entry

Benefit from targeted mentorship on market entry strategy, operations, and legal frameworks—ensuring a seamless and compliant expansion.

Product Optimization for U.S. Healthcare

Adapt and position your solution to meet the priorities of U.S. healthcare systems, driving stronger adoption and market traction.

Exclusive Stakeholder Access

Leverage curated introductions to high-level providers, investors, and industry partners to accelerate growth and partnerships.

Investor Alignment

Direct connections to industry-relevant investors and in-depth insights into the U.S. venture capital landscape.

What We Help With

___

U.S. Healthcare Landscape

Master the complexities of the U.S. healthcare landscape so you can navigate key payor models, insurance structures, and regulatory processes.

___

Regulatory and Compliance

Garner an understanding of how your product meets U.S. regulatory standards, including FDA processes, data privacy laws, and intellectual property protection.

___

Market Validation and U.S. Alignment

Deepen your understanding of U.S. healthcare dynamics, refining product-market fit to address the priorities of providers and payors and strengthen your path to adoption.

___

Capital Strategy and Investor Alignment

Refine your fundraising approach by engaging with U.S. investors, optimizing for due diligence, and positioning your company to secure capital for scale.

___

Strategic Partnerships and Market Access

Gain direct access to and build high-value relationships with U.S. healthcare stakeholders including payors, providers, investors, and industry partners.

___

Market Adoption and Scaling

Learning strategies for scaling your customer base, driving sustained adoption, and building long-term retention in the U.S. healthcare market.

Cohort Format

The U.S. Market Access Program optimizes your time and our network with both virtual and in-person elements.

virtual

Weekly Virtual Sessions

Beginning 23 February 2026

  • 3 weeks of interactive sessions
  • 2 hours per week
  • Led by our curated network of industry leaders, investors, and subject matter experts
in-person

On the Ground in Philadelphia

16-20 March 2026

  • Five days of high-touch learning designed for depth and real-world application
  • Daily 1:1 access to investors and industry experts
  • Enhance your Philadelphia visit by tapping into two premier industry gatherings:

Key Partners

Cohort Details

We're seeking growth-stage medtech, diagnostics, device, and digital health companies ready to expand beyond their home markets.

Explore our Investor Network

Eligibility

  • Demonstrated traction in their country of origin
  • Raised $5M+ USD in capital
  • A full-time, dedicated team
  • The resources and intent to enter the U.S. market, including the ability to commit time, funding, and personnel to the program
  • Applicants must attend both virtual and in-person components

Applicants should be actively planning or pursuing U.S. market entry and have the legal and operational flexibility to take the next steps.

Timing

14 November

Application deadline

1-31 December

Applicant interviews and company selection notification

23 February

Cohort begins

16 March

Onsite in Philadelphia

Commercialize in the U.S.

Why the Science Center

We strengthen your ability to lead and scale by stress-testing your business model, equipping your team with the tools to navigate complexity, and connecting you with payors, providers, investors, and industry leaders who drive market success. From regulatory strategy to capital access, we’re your partner in building companies that grow faster, stronger, and with impact that lasts.

Why Philadelphia

Philadelphia offers global companies a strategic gateway into the U.S. market. Home to top research institutions, leading hospitals, and a thriving life sciences ecosystem, the city blends deep healthcare expertise with a collaborative, innovation-driven culture. Its location between New York and Washington, D.C. provides direct access to major markets, investors, and policymakers—at a more accessible cost than other hubs. For global companies ready to scale, Philadelphia delivers the connections, resources, and momentum to succeed.

Your Investment

Breaking into the U.S. healthcare market without the right connections can cost upwards of $500K–$1M in delays, missteps, and missed opportunities. Get the network, strategy, and support you need—for a fraction of the cost of going it alone.

Your Investment Includes:

2 team members

per company

3 virtual sessions

with industry experts

1:1 expert advisory sessions

with mentors & investors

5 days on site in Philadelphia including:

  • access to select conferences during site visit
  • custom mentor feedback dashboard
  • access to investor discovery resources
  • discounts or special access to Science Center events (as available)

The Latest

Global Alumni Snapshot


Raised $4.2M including includes capital from the Mayo Clinic; conducting clinical trials for FDA approval in the U.S.

"The web of connections we got while in Philadelphia is something I wouldn’t have been able to do on my own in less than 6 months."
-- Moshe Barel, CEO


The Science Center connected the SpotItEarly to a leading U.S. academic medical center where the company is currently undergoing clinical trials. Raised a total of $20M USD.


"The program sharpened my understanding of how to approach the market and helped expand my network, in a way that contributed to my investors belief that we can have a successful GTM."
-- Tal Shapsa Heiman, CEO

Questions?

Reach out to us to learn more.

Contact us
Firsthand instructor w girl student

Proven Results

5
U.S. Market Access cohorts
50
global companies supported since 2022
$80M
Raised since 2022-2023 participation
$114M
Total raised to date
Our impact

All companies have active ties to the U.S. market, including clinical trials, pilots, revenue-generating contracts, U.S. investors, and/or U.S.-based advisors or team members